Pay in 4 interest-free payments of $7.41 Learn more
Ships within 48 hours · Estimated delivery Sep 2 - Sep 7
The Phase 2 trial results Published in the New England Journal of Medicine, the Phase 2 trial showed that participants receiving the highest dose of retatrutide (12mg weekly) achieved a mean weight reduction of 24.2% at 48 weeks
It's a daily pill offering unparalleled dosing flexibility
Amlioration de la peau : Le glutathion aide rtrcir les pores, rparer les barrires endommages et rendre la peau plus dlicate et plus lisse
HC participants In total, 71 healthy participants aged 18 years or older, lacking neurological or psychiatric disorders, were enrolled
a pinch of black pepper improves curcumin absorption
Eli Lilly published the results of its ATTAIN-1b trial for obesity in September 2025 7 , which compared orforglipron to placebo in more than 3,100 adults without diabetes, with a BMI of 30+ or 27-30 with an obesity-related complication including hypertension, dyslipidaemia, cardiovascular disease or obstructive sleep apnoea and a history of at least one patient-reported unsuccessful dietary effort to lose body weight, who have tried unsuccessfully to lose weight with diet alone
US$ 26.02
US$ 27.43
US$ 20.07
